Life science News and Research

RSS

TAP to showcase ambr system at Cell Line Development and Engineering 2010

The Automation Partnership, a world leader in the design and development of innovative automation for life science applications, is pleased to announce it will be showcasing its new advanced micro bioreactor system (ambr™) at Cell Line Development and Engineering 2010, February 25-26 in San Francisco, USA.

15 Feb 2010

Corey McPherson Nash, Biogen Idec team up to create new website for life science community

Corey McPherson Nash (www.corey.com), a leading national branding and design firm, recently partnered with Biogen Idec to create a new Web site design for the life sciences company.

12 Feb 2010

Strategic Diagnostics is now SDIX

Strategic Diagnostics Inc., a leading provider of biotechnology-based products and services for a broad range of life science, biotechnology, diagnostic, and food safety applications, today announced it will be doing business as SDIX (Strategic Diagnostics Inc. d/b/a SDIX).

11 Feb 2010

BioMed Realty Trust announces financial results for fourth-quarter and full-year ended December 31, 2009

BioMed Realty Trust, Inc., a real estate investment trust focused on Providing Real Estate to the Life Science Industry®, today announced financial results for the fourth quarter and full-year ended December 31, 2009.

10 Feb 2010

AB SCIEX technology solution implemented for anti-doping enforcement at the 2010 Winter Games

While millions of viewers around the world are watching breathtaking ski jumps, razor-sharp skating moves and other awe-inspiring athletic feats in Vancouver over the next few weeks, the official doping control laboratory of the 2010 Winter Games will be casting an equally intent eye on the athletes who are competing.

10 Feb 2010

Model Metrics launches Pharma2GO sales force automation solution for pharma and life science industries

Model Metrics has launched Pharma2GO Spring '10, a comprehensive sales force automation solution specifically designed for the pharmaceutical and life science industries that extends the power of Salesforce CRM to mobile devices.

10 Feb 2010

Sony acquires iCyt Mission Technology

Sony Corporation (Sony) announced today that it has acquired iCyt Mission Technology, Inc. (iCyt), a leading producer of high-performance cell sorters used for stem cell and disease research, through its U.S. subsidiary, Sony Corporation of America (SCA).

10 Feb 2010

BIO urges HHS to preserve incentives for investment and innovation; improve patient access to genetic tests

The Biotechnology Industry Organization (BIO) released today a letter to Health and Human Services Secretary Kathleen Sebelius regarding the potentially harmful recommendations of the Secretary’s Advisory Committee on Genetics, Health and Society (SACGHS) in its Report on Gene Patents and Licensing Practices and Their Impact on Patient Access to Genetic Tests.

6 Feb 2010

Molecular Devices brand re-launched into life sciences marketplace

Today, Molecular Devices, Inc.—now part of Danaher Corporation—re-launched the Molecular Devices brand into the life sciences marketplace. The renewed corporate brand is focused primarily on meeting customer needs and exceeding customer expectations, and includes an evolved visual identity system.

From Danaher 4 Feb 2010

Danaher acquires Life Technologies' mass spectrometry business

Life Technologies Corporation, a provider of innovative life science solutions, has completed the previously announced sale of its mass spectrometry business to Danaher Corporation for $450 million in cash, subject to a conventional working capital adjustment.

From Danaher 2 Feb 2010

Cellectricon resumes litigation against Fluxion Biosciences over alleged patent infringement

Cellectricon AB today announced that it has resumed its litigation against Fluxion Biosciences, Inc. Cellectricon filed the lawsuit in July 2009 in the United States District Court for the Northern District of California alleging infringement of several United States patents issued or licensed to Cellectricon for microfluidic technology used in Cellectricon's state-of-the-art ion channel drug screening solution, the Dynaflow(R)HT System. Cellectricon's U.S. Patents Nos. 7,390,650, 7,470,518 and 7,563,614 have been asserted in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros, and licensed to Cellectricon.

From Fluxion Biosciences 2 Feb 2010

Thermo Fisher Scientific to acquire Finnzymes

Thermo Fisher Scientific Inc., the world leader in serving science, announced today that it has signed a definitive agreement to acquire Finnzymes, a well-recognized provider of integrated tools for molecular biology analysis, including reagents, instruments, consumables and kits. Headquartered in Espoo, Finland, Finnzymes has 90 employees and generated revenue of $20 million in 2009.

From Thermo Fisher Scientific Inc. 2 Feb 2010

Danaher acquires AB SCIEX and Molecular Devices

Danaher Corporation announced today that it has completed the previously announced acquisition of AB SCIEX and Molecular Devices.

From Danaher 1 Feb 2010

New testing method for early detection of cancer

A new testing method is being developed to detect cancer soon after the tumor has formed. It will identify characteristic substances in the blood which accompany a certain type of tumor. The first steps in the development have already been completed.

1 Feb 2010

Enzo Biochem generating more than $100M in revenues annually

Enzo Biochem, Inc. is well positioned to benefit from the results of its transformation involving acquisitions, new managements at each of its major subsidiaries and a heightened focus on new life science, diagnostic and therapeutic products, Barry Weiner, President, told the annual meeting of shareholders today.

30 Jan 2010

Delaware Bio members support bioscience educational initiatives

Last night at the second annual Delaware Bio Winterfest, Delaware BioScience Association provided the Junior Achievement of Delaware with financial support of $6555.00 to aid in the outfitting of the new Innovation hub.

30 Jan 2010

WBTshowcase chooses Penman PR as public relations representative for WBT2010

WBTshowcase is pleased to announce the selection of Penman PR as the organization’s public relations representative for WBT2010. WBTshowcase is the world's largest forum offering a prescreened, pre-prepped collection of undiscovered companies and intellectual property emanating from top universities, labs and research institutions from across the country.

30 Jan 2010

Amarin reviews 2009 accomplishments; outlines strategy for 2010 and beyond

Amarin Corporation plc, a clinical-stage biopharmaceutical company focused on improving the treatment of cardiovascular disease, today issued a special letter to its shareholders.

28 Jan 2010

Life Technologies announces a series of investments and new technologies for genetic sequencing research

Life Technologies Corporation (NASDAQ:LIFE), a provider of innovative life science solutions, today announced a series of investments and new technologies designed to extend the use of sequencing in the research arena and make it more relevant for physicians.

28 Jan 2010

MedCI forms new strategic alliance with Genta

MedCI LLC, a life-science business consulting services company, announced the formation of a new strategic alliance with Genta Incorporated to secure licensing partners for Genta’s small molecule oncology compound, tesetaxel.

28 Jan 2010